Dexlansoprazole (DEXILANT): Difference between revisions
From SEHK Wiki
No edit summary Tag: Reverted |
No edit summary Tag: Reverted |
||
| Line 51: | Line 51: | ||
==Renal Dose Adjustments== | ==Renal Dose Adjustments== | ||
No renal dose adjustment recommended | No renal dose adjustment recommended | ||
==Side Effects== | |||
Revision as of 02:22, 6 January 2025
Drug class: Proton Pump Inhibitors (PPI)
Dexlansoprazole (中文: 右蘭索拉唑)
Drug Class
Proton Pump Inhibitors (PPI)
Common Strengths of Dexlansoprazole capsule
Dexlansoprazole capsule are available in the following strengths:
- 30 mg delayed-release capsules
- 60mg delayed-release capsules
Drug Trade Names of Dexlansoprazole capsule
Dexilant
Drug Usage
Dexlansoprazole is used for:
- Healing of erosive esophagitis (EE)
- Maintenance of healed erosive esophagitis (EE)
- Treatment of gastroesophageal reflux disease (GERD)
Mechanism of Action
Inhibits (H+/K+ )-ATPase enzyme in the gastric parietal cells, blocking gastric acid production in the stomach
Route of Administration
Oral
Dosages
For adults and children aged 12 years and older, the typical dosage is:
Healing: 60 mg once daily for up to 8 weeks
Maintenance: 30 mg once daily for up to 6 months
GERD: 30 mg once daily for up to 4 weeks
Renal Dose Adjustments
No renal dose adjustment recommended
